本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SAB Biotherapeutics, Inc.

3.46
+0.05001.47%
盤前3.520.0600+1.73%07:09 EDT
成交量:23.75萬
成交額:82.29萬
市值:3.15億
市盈率:-2.22
高:3.51
開:3.42
低:3.40
收:3.41
52周最高:5.15
52周最低:1.85
股本:9,098.64萬
流通股本:6,204.34萬
量比:0.78
換手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-1.5562
每股收益(LYR):-0.7944
淨資產收益率:-11.27%
總資產收益率:-33.46%
市淨率:1.47
市盈率(LYR):-4.36

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/19

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/22

重要事件披露

Form 8-K - Current report
2026/03/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/19

重要事件披露

Form 8-K - Current report
2026/03/10

重要事件披露

Form 8-K - Current report